The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

被引：0
|
作者：
Irene Catucci
Paolo Radice
Roger L. Milne
Fergus J. Couch
Melissa C. Southey
Paolo Peterlongo
机构：
[1] IFOM,Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine
[2] Fondazione Istituto FIRC di Oncologia Molecolare,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[3] Fondazione IRCCS Istituto Nazionale dei Tumori,Genetic Epidemiology Laboratory, Department of Pathology
[4] Cancer Epidemiology Centre,undefined
[5] Cancer Council Victoria,undefined
[6] University of Melbourne,undefined
[7] Department of Laboratory Medicine and Pathology,undefined
[8] Mayo Clinic,undefined
[9] The University of Melbourne,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Breast cancer predisposition; Breast cancer genetic risk factor; p.Leu939Trp; VUS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Breast Cancer Gene PALB2 High Lifetime Risk
    不详
    GYNAKOLOGE, 2015, 48 (02): : 87 - 87
  • [22] Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer
    Poumpouridou, Nikoleta
    Goutas, Nikolaos
    Tsionou, Christina
    Dimas, Kleanthi
    Lianidou, Evi
    Kroupis, Christos
    FAMILIAL CANCER, 2016, 15 (02) : 183 - 191
  • [23] Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
    T K Foo
    M Tischkowitz
    S Simhadri
    T Boshari
    N Zayed
    K A Burke
    S H Berman
    P Blecua
    N Riaz
    Y Huo
    Y C Ding
    S L Neuhausen
    B Weigelt
    J S Reis-Filho
    W D Foulkes
    B Xia
    Oncogene, 2017, 36 : 4161 - 4170
  • [24] Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer
    Nikoleta Poumpouridou
    Nikolaos Goutas
    Christina Tsionou
    Kleanthi Dimas
    Evi Lianidou
    Christos Kroupis
    Familial Cancer, 2016, 15 : 183 - 191
  • [25] Mutation analysis of PALB2 gene in French breast cancer families
    Francesca Damiola
    Inès Schultz
    Laure Barjhoux
    Valérie Sornin
    Marie-Gabrielle Dondon
    Séverine Eon-Marchais
    Morgane Marcou
    Olivier Caron
    Marion Gauthier-Villars
    Antoine de Pauw
    Elisabeth Luporsi
    Pascaline Berthet
    Capucine Delnatte
    Valérie Bonadona
    Christine Maugard
    Pascal Pujol
    Christine Lasset
    Michel Longy
    Yves-Jean Bignon
    Jean-Pierre Fricker
    Nadine Andrieu
    Olga M. Sinilnikova
    Dominique Stoppa-Lyonnet
    Sylvie Mazoyer
    Danièle Muller
    Breast Cancer Research and Treatment, 2015, 154 : 463 - 471
  • [26] PALB2 and the Risk for Colorectal Cancer
    Streit, Spencer
    Mathew, Reshmi
    Ali, Aleem
    Jadeja, Sonal
    Stemboroski, Lauren
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1428 - S1428
  • [27] Breast-Cancer Risk in Families with Mutations in PALB2
    Lee, Ann S. G.
    Ang, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1650 - 1651
  • [28] The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
    Heikkinen, Tuomas
    Karkkainen, Hanni
    Aaltonen, Kirsimari
    Milne, Roger L.
    Heikkila, Paivi
    Aittomaki, Kristiina
    Blomqvist, Carl
    Nevanlinna, Heli
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3214 - 3222
  • [29] A novel PALB2 truncating mutation in an Italian family with male breast cancer
    Vietri, Maria Teresa
    Caliendo, Gemma
    Casamassimi, Amelia
    Cioffi, Michele
    De Paola, Maria Laura
    Napoli, Claudio
    Molinari, Anna Maria
    ONCOLOGY REPORTS, 2015, 33 (03) : 1243 - 1247
  • [30] Breast-Cancer Risk in Families with Mutations in PALB2 Reply
    Antoniou, Antonis C.
    Foulkes, William D.
    Tischkowitz, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1651 - 1652
12345